UK Dirty Money Flows Estimated at 325bn Annually Sparking Regulatory Concerns Setting Up Brokerage Accounts for Grandchildren What to Know About Using a Parents Name Inflation Pressures Persist Ahead of Memorial Day Weekend With Travel and Food Costs Rising Most Toyota Pauses NextGen Lexus EV Development Amid Strategy Shift South Koreas Deputy PM Warns AI Wealth Must Serve Public Amid Samsung Labor Disputes Subramanian Swamy Calls for Ban on Cement Imports from Pakistan Citing Security Risks INVE Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed KVYO Q1 2026 Earnings EPS Surprises by 102 as Stock Gains 37 VAL Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Offshore Drilling Market LNZA Q4 2025 Earnings Loss Narrower Than Expected Shares Slide FB Financial Q1 2026 Earnings Slight EPS Miss Amid Stable Core Performance Covenant Logistics Group Inc CVLG Q1 2026 Earnings Slight EPS Miss as Shares Edge Higher Amidst Challenging Freight Environment GE HealthCare Technologies GEHC Trading Flat Consolidating Between Key Levels Neumora Therapeutics NMRA Stock Holds Steady at 185 as Key Support and Resistance Levels Tighten VirTra Inc VTSI Declines 187 as Shares Test Key Support Level Repay Holdings RPAY Holds Steady Near Support Amid Modest Uptick Omega Healthcare Investors OHI Eases from Support Zone Amid Sector Headwinds MGPI Q1 2026 Earnings Significant EPS Beat Bolstered by Operational Efficiency BGS Q1 2026 Earnings Strong EPS Surprise Yet Shares Decline Crescent Biopharma Inc CBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Himalaya Shipping Ltd HSHP Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Community Health Systems Inc Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Move Lindblad Expeditions Holdings Inc LIND Q1 2026 Earnings Strong Profit Beat Drives Share Rally SpaceXs Starlink Revenue Drives Growth as Company Eyes Potential Nasdaq Listing CACC Q1 2026 Earnings EPS Slightly Misses Estimates Amid Subprime Auto Lending Landscape Xeris Biopharma XERS Declines 298 as Stock Tests Key Support Levels